Sanctions Screening for Research Partners: Obligations

Introduction

Sanctions screening for research partners refers to the process of checking whether universities, biotechnology companies, laboratories, sponsors, funders, suppliers, or individual researchers are subject to applicable sanctions or export-control restrictions before entering into or continuing an international collaboration.

Biotechnology research may involve the transfer of biological samples, genetic data, laboratory equipment, technical knowledge, software, and research funding. If a partner is sanctioned or connected with a prohibited end user, such transfers may violate trade restrictions, financial sanctions, or national-security laws.

Screening is therefore an important part of research governance. However, there is no single global sanctions list or universal screening obligation. The legal duty depends on the relevant jurisdiction, the parties, the items or services involved, and the transaction’s connection to a particular country.

Legal Obligations

1. Screening before collaboration

Research institutions should screen foreign partners before signing a memorandum of understanding, grant agreement, material-transfer agreement, or research contract. Screening should cover the institution, principal investigators, sponsors, intermediaries, and relevant beneficial owners.

U.S. universities, for example, commonly screen partners against government restricted-party lists before entering agreements or transferring controlled research materials.

The University of Chicago+1

2. Assessing the scope of restrictions

A listed party is not automatically prohibited from every activity. The legal effect depends on the list, applicable sanctions programme, transaction, funding source, and whether a licence or exception is available. A potential match should therefore be reviewed rather than treated as an automatic finding of illegality.

Office of Ethics and Compliance

3. Screening throughout the relationship

Screening should be repeated when a partner’s status changes, a new institution joins the project, funding changes, or research materials are transferred. A previously lawful collaboration may require reassessment if sanctions or export-control restrictions are updated.

4. Export-control review

Sanctions screening does not replace export classification and licensing. Even where a research partner is not sanctioned, biological materials, technical data, equipment, or software may be controlled. India’s SCOMET framework and applicable foreign export-control laws may impose separate authorisation requirements.

Case Laws and Enforcement Examples

*1. Indiana University — BIS Settlement (2024)

The U.S. Bureau of Industry and Security settled allegations concerning 42 unlicensed exports of genetically modified fruit flies producing a controlled toxin subunit to research institutions and universities worldwide. Indiana University voluntarily disclosed the conduct, cooperated, and implemented remedial measures. The settlement required compliance training and other corrective steps.

Bureau of Industry and Security+1

This enforcement action demonstrates that universities and research centres must assess the controlled nature of biological materials and the licensing implications of transfers to research partners. It is an administrative settlement, not a court judgment specifically establishing a screening duty.

*2. Princeton University — BIS Enforcement (2021)

Princeton University agreed to pay a civil penalty following export-control violations involving biological materials sent to overseas research institutions. The university also had to conduct internal and external compliance audits. Voluntary disclosure and cooperation were relevant to the resolution.

bis.doc.gov

The case illustrates that academic research does not automatically exempt institutions from export-control requirements. Partner screening must be combined with item classification, licence review, and documented compliance procedures.

These are enforcement examples rather than judicial precedents. They provide practical guidance on the legal risks of international research transfers.

Indian Legal Framework

In India, relevant laws include:

Foreign Trade (Development and Regulation) Act, 1992: Provides the legal framework for export restrictions and authorisations.

SCOMET controls: Regulate specified dual-use goods, software, technology, and biological materials.

Weapons of Mass Destruction and their Delivery Systems (Prohibition of Unlawful Activities) Act, 2005: Restricts prohibited dealings involving weapons of mass destruction and related materials or technology.

Applicable UN sanctions: Must be observed as implemented through Indian legal instruments.

The precise duty to screen a research partner depends on the activity and applicable law. A routine research collaboration may not itself be prohibited, but transferring controlled materials or technology to a restricted party may require authorisation or be barred.

Conclusion

Sanctions screening for research partners is a key element of responsible international biotechnology collaboration. Institutions should screen partners before engagement, assess the precise legal effect of any listing, verify end use, classify research materials, obtain necessary licences, and repeat screening when circumstances change.

The Indiana University and Princeton University enforcement examples show that research institutions can face penalties and compliance obligations for unauthorised transfers of biological materials. They also demonstrate why screening should not be treated as a one-time administrative formality. Effective compliance requires ongoing due diligence, legal review, accurate documentation, and a clear process for resolving potential matches before the collaboration proceeds.